Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer

NCT00004032 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Recurrent Ovarian Epithelial Cancer

Interventions

BIOLOGICAL: ALVAC-hB7.1
BIOLOGICAL: recombinant interferon gamma
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)